Abstract
This experiment tested whether bromocriptine or desmethylimipramine (DMI), both agents used clinically to treat cocaine abuse, could specifically alter behavior maintained by cocaine injections. Rhesus monkeys were trained to press a lever in daily experimental sessions under a three-component multiple schedule of reinforcement. In the first and third components, food was available under a fixed-ratio (FR) 30 schedule. In the second component cocaine (0.025 or 0.050 mg/kg/injection, IV) was available under a FR 30 schedule. Monkeys received continuous (24 h/day) IV infusions of several doses of bromocriptine or DMI. Bromocriptine (0.8–6.4 mg/kg/day) was infused for at least the same number of sessions as was required for responding to decline to low levels when the monkeys were allowed to self-administer saline. DMI (0.8–12.8 mg/kg/day) was infused for a minimum of 3 weeks. In some instances, low doses of bromocriptine decreased responding maintained by cocaine without reducing food-maintained responding, while higher doses of bromocriptine decreased responding maintained by either food or cocaine. However, bromocriptine doses that reduced cocaine intake also caused overt stimulation of locomotor activity. In contrast, DMI, at doses as much as 10 times higher than those used clinically to treat cocaine abuse did not affect responding maintained by cocaine or food. These results indicate that bromocriptine can selectively reduce behavior maintained by cocaine, although apparently by a mechanism other than blockade of reinforcing effects. On the other hand, DMI did not alter the reinforcing effects of either cocaine or food under these conditions.
Similar content being viewed by others
References
Banerjee AP, Kung LS, Riggi ST, Chanda SK (1977) Development of β-adrenergic receptor subsensitivity in antidepressants. Nature 268:455–456
Banerjee SP, Sharma VK, Kung-Cheung LS, Chanda SK, Riggi SJ (1979) Cocaine andd-amphetamine induce changes in central β-adrenoceptor sensitivity: effects of acute and chronic drug treatment. Brain Res 175:119–130
Charney DL, Redmond DE, Leckman JF, Maas JW, Roth RH (1981) Presynaptic adrenergic receptor sensitivity in depression: the effect of chronic desipramine treatment. Arch Gen Psychiatry 38:1334–1340
Crews FT, Smith CB (1978) Pre-synaptic α-receptor subsensitivity after long-term antidepressant treatment. Science 202:322–324
Dackis CA, Gold MS (1985) Bromocriptine as a treatment for cocaine abuse: the dopamine depletion hypothesis. Int J Psychiatry Med 15:125–135
Dackis CA, Gold MS, Sweeney DR (1987a) The physiology of cocaine craving and ‘crashing’. Arch Gen Psychiatry 44:298–300
Dackis CA, Gold MS, Sweeney DR, Byron JPJ, Climko R (1987b) Single-dose bromocriptine reverses cocaine craving. Psychiatry Res 20:261–264
deWit H, Wise RA (1977) Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J Psychol 31:195–203
Dole VP, Joseph H (1978) Long term outcome of patients treated with methadone maintenance. Ann NY Acad Sci 311:181–189
Garza R dela, Johanson CE (1982) Effects of haloperidol and physostigmine on self-administration of local anesthetics. Pharmacol Biochem Behav 17:1295–1299
Gawin FH (1988) Chronic neuropharmacology of cocaine: progress in pharmacotherapy. J Clin Psychiatry 49:11–16
Gawin FH, Kleber HD (1984) Cocaine abuse treatment: open pilot trial with desipramine and lithium carbonate. Arch Gen Psychiatry 41:903–910
Gawin FH, Kleber HD (1988) Evolving conceptualizations of cocaine dependence. Yale J Biol Med 61:123–136
Gawin FH, Kleber HD, Byck R, Rounsaville BJ, Kosten TR, Jatlow PI, Morgan C (1989) Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 46:117–121
Giannini AJ, Malone DA, Giannini MC, Price WA, Loiselle RH (1986) Treatment of depression in chronic cocaine and phencyclidine abuse with desipramine. J Clin Pharmacol 26:211–214
Gill CA, Holz WC, Zircle CL, Hill H (1978) Pharmacological modification of cocaine and apomorphine self-administration in the squirrel monkey. In: Deniker P, Radouco-Thomas C, Villeneuve A (eds) Proceeding of the 10th Congress of the Collegium Internationale Neuro-Psychopharmacologicum. Pergamon Press, New York, pp 1477–1484
Herling S, Downs DA, Woods JH (1979) Cocaine,d-amphetamine and pentobarbital effects on responding maintained by food or cocaine in rhesus monkeys. Psychopharmacology 64:261–269
Jackson DM, Jenkins OF, Ross SB (1988) The motor effects of bromocriptine — a review. Psychopharmacology 95:433–446
Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219–1223
Roberts DCS, Koob GF (1982) Disruptions of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol Biochem Behav 17:901–904
Roberts DC, Vickers G (1984) Atypical neuroleptics increase self-administration of cocaine: an evaluation of a behavioural screen for antipsychotic activity. Psychopharmacology 82:135–139
Roberts DCS, Koob GF, Klonoff P, Flbiger HC (1980) Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol Biochem Behav 12:781–787
Seiden LS, Dykstra LA (1977) Psychopharmacology. A biochemical and behavioral approach. Van Nostrand Reinhold Company, New York, pp 287–288
Taylor D, Ho BT, Fagan JD (1979) Increased dopamine receptor binding in rat brain by repeated cocaine injection. Commun Psychopharmacol 3:137–142
Tennant FS, Rawson RA (1983) Cocaine and amphetamine dependence treated with desipramine. In: Harris LS (ed) Problems of drug dependence. NIDA Research Monograph 43. US Government Printing Office, Washington DC, pp 351–355
Tennant FS, Sagherian AA (1987) Double-blind comparison of amantidine and bromocriptine for ambulatory withdrawal from cocaine dependence. Arch Intern Med 147:109–112
Wilson MC, Schuster CR (1973) The effects of stimulants and depressants on cocaine self-administration behavior in the rhesus monkey. Psychopharmacologia 31:291–304
Woods JH, Herling S, Winger G (1978) Chlorpromazine and haloperidol-induced changes in some behavioral effects of cocaine and amphetamine. In: Deniker P, Radouco-Thomas C, Villeneuve A (eds) Proceedings of the Tenth Congress of the Collegium International Neuro-Psychopharmacologicum. Pergamon Press, New York, pp 1485–1502
Woolverton WL (1986) Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacol Biochem Behav 24:531–535
Woolverton WL (1987) Evaluation of the role of norepinephrine in the reinforcing effects of psychomotor stimulants in rhesus monkeys. Pharmacol Biochem Behav 26:835–839
Woolverton WL, Goldberg LI, Ginos JZ (1984) Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J Pharmacol Exp Ther 230:678–683
Woolverton WL, Virus RM (1989) The effects of a D1 and a D2 dopamine antagonist on behavior maintained by cocaine or food. Pharmacol Biochem Behav 32:691–697
Yokel RA, Wise RA (1978) Amphetamine-type reinforcement by dopamine agonists in the rat. Psychopharmacology 58:289–296
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kleven, M.S., Woolverton, W.L. Effects of bromocriptine and desipramine on behavior maintained by cocaine or food presentation in rhesus monkeys. Psychopharmacology 101, 208–213 (1990). https://doi.org/10.1007/BF02244128
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244128